Vijaya Diagnostic Centre Limited (VIJAYA)

Price455.60 -10.05 (-2.16%)52 Week High529.00
ISININE043W0102452 Week Low349.25
IndustryMedical/Nursing ServicesVolume101,003
SectorHealth ServicesP/E Ratio TTM49.96
Market Cap47.5 B1 Year Beta0.60
Technical Rating of

Vijaya Diagnostic Centre Limited (VIJAYA) logo

Vijaya Diagnostic Centre Limited (VIJAYA) is an Indian diagnostic laboratory chain headquartered in Hyderabad, Telangana, India. It was founded in 1981 by Dr. K. Vijayanand.

VIJAYA is a leading diagnostic laboratory chain in India. It has a network of over 200 laboratories across India. The company offers a wide range of diagnostic tests, including:

  • Blood tests: VIJAY offers a range of blood tests, such as complete blood count (CBC), liver function tests (LFTs), and kidney function tests (KFTs).
  • Urine tests: VIJAY offers a range of urine tests, such as urinalysis, urine culture, and urine pregnancy test.
  • Imaging tests: VIJAY offers a range of imaging tests, such as X-rays, ultrasounds, and CT scans.
  • Other tests: VIJAY also offers a range of other tests, such as ECG, EEG, and spirometry.

VIJAYA’s laboratories are accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The company has a strong track record of growth and profitability. The company’s revenue has grown at a CAGR of 15% in the last 5 years.

VIJAYA is well-positioned for future growth. The company is benefiting from the growth of the Indian healthcare sector. The company is also expanding its network of laboratories and adding new tests to its portfolio.

VIJAYA faces some challenges, such as competition from other diagnostic laboratory chains and the need to invest in new technologies. However, the company is well-positioned to overcome these challenges and continue to grow in the future.

Here are some of VIJAY’s strengths:

  • Strong brand name: VIJAY is a well-known and respected brand in the Indian diagnostic laboratory market.
  • Strong track record of growth: VIJAY has a strong track record of growth, with its revenue and profits growing at a CAGR of 15% in the last 5 years.
  • Experienced management team: VIJAY has an experienced management team with a proven track record of success in the diagnostic laboratory industry.
  • Wide network of laboratories: VIJAY has a wide network of laboratories across India, which gives it a competitive advantage over its rivals.
  • Accredited laboratories: VIJAY’s laboratories are accredited by NABL, which assures the quality of its tests.

Here are some of VIJAY’s challenges:

  • Competition: VIJAY faces competition from other diagnostic laboratory chains, such as Metropolis Healthcare, Dr. Lal PathLabs, and Thrive Global.
  • Regulation: VIJAY is subject to regulation by the government of India, which can sometimes be complex and time-consuming.
  • Technology: VIJAY needs to keep up with the latest technological advancements in order to stay ahead of the competition.
  • Customer acquisition: VIJAY needs to continue to acquire new customers in order to sustain its growth.

Overall, VIJAY is a well-positioned company with a strong track record of performance. The company is committed to innovation and is well-positioned to continue its growth in the coming years.

          

Vijaya Diagnostic Centre Limited (VIJAYA) Chart

Technical Analysis of Vijaya Diagnostic Centre Limited (VIJAYA)

Moving Averages

PeriodSimpleExponential
MA 5474.81469.73
MA 10478.05476.37
MA 20488.21480.20
MA 30484.34478.95
MA 50473.63471.71
MA 100441.88453.63
MA 200425.25439.77

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)0.00Aroon Down (14)100.00
MACD Level (12, 26)-1.93MACD Signal (12, 26)2.50
Relative Strength Index (7)24.85Relative Strength Index (14)36.41
Stochastic %D (14 3 3)16.76Stochastic %K (14 3 3)7.86
Stochastic RSI Fast (3, 3, 14, 14)1.86Stochastic RSI Slow (3, 3, 14, 14)9.29
Bollinger Upper Band (20)518.10Bollinger Lower Band (20)458.31
Keltner Channels Upper Band (20)514.62Keltner Channels Lower Band (20)445.78
Donchian Channels Upper Band (20)529.00Donchian Channels Lower Band (20)453.00
Ichimoku Conversion Line (9, 26, 52, 26)480.13Ichimoku Base Line (9, 26, 52, 26)491.00
Ichimoku Leading Span A (9, 26, 52, 26)470.20Ichimoku Leading Span B (9, 26, 52, 26)448.85
Positive Directional Indicator (14)17.98Negative Directional Indicator (14)20.72
Volume Weighted Average Price458.72Volume Weighted Moving Average 20489.93

Oscillator Rating

Oscillators

Awesome Oscillator-3.42
Ultimate Oscillator (7,14,28)32.97
Money Flow (14)10.78
Chaikin Money Flow (20)-0.23
Commodity Channel Index (20)-202.94
Bull Bear Power-36.31

High / Low

1 Month529.00453.00
3 Month529.00437.25
6 Month529.00349.25
52 Week529.00349.25
All Time672.00295.00

Volume

Volume101,003.00
Average 10 D178.3 T
Average 30 D185.7 T
Average 60 D164.7 T
Average 90 D254 T

Change/Volatility

Change-10.05 (-2.16%)
Change 1W-36.80 (-7.47%)
Change 1M-65.40 (-12.55%)
Volatility3.21
Volatility W3.69

Performance

Yesterday3.78
Weekly-7.20
Monthly-4.93
3 Month0.59
6 Month18.34
Yearly12.77
5 Year-15.63
All Time-15.63

Misc.

Average Day Range (14)16.11
Average Directional Index (14)26.55
Average True Range (14)17.33
Williams Percent Range (14)-95.49
Rate Of Change (9)-6.21
Hull Moving Average (9)466.41
Momentum (10)-28.20
Parabolic SAR506.37

PIVOT POINTS of Vijaya Diagnostic Centre Limited (VIJAYA)

NameS3S2S1Pivot PointsR1R2R3
Classic313.42404.47462.73495.52553.78586.57677.62
Fibonacci404.47439.25460.74495.52530.30551.79586.57
Camarilla495.96504.31512.65495.52529.35537.69546.04
Woodie's392.43414.84483.48505.89574.52596.94665.57
DeMark's - - 479.13503.71570.17 - -

Financial Analysis of Vijaya Diagnostic Centre Limited (VIJAYA)

Income Statement

Basic EPS (FY)8.29
Basic EPS (TTM)9.15
EBITDA (Annual YoY Growth)-10.27
EBITDA (Quarterly QoQ Growth)-2.01
EBITDA (Quarterly YoY Growth)20.62
EBITDA (TTM)1.9 B
EBITDA (TTM YoY Growth)1.89
EPS Diluted (Annual YoY Growth)-22.77
EPS Diluted (FY)8.26
EPS Diluted (MRQ)2.60
EPS Diluted (Quarterly QoQ Growth)-4.25
EPS Diluted (Quarterly YoY Growth)50.94
EPS Diluted (TTM)9.12
EPS Diluted (TTM YoY Growth)-0.72
Free Cash Flow (Annual YoY Growth)0.51
Free Cash Flow Margin (FY)10.04
Gross Profit (Annual YoY Growth)-5.72
Gross Profit (FY)2.3 B
Gross Profit (MRQ)734.4 M
Gross Profit (Quarterly QoQ Growth)-1.53
Gross Profit (Quarterly YoY Growth)27.33
Gross Profit (TTM YoY Growth)9.63
Last Year Revenue (FY)4.6 B
Revenue (Annual YoY Growth)-0.68
Revenue per Employee (FY)1.7 M
Revenue (Quarterly QoQ Growth)0.05
Revenue (Quarterly YoY Growth)15.99
Revenue (TTM YoY Growth)7.18
Net Income (Annual YoY Growth)-22.84
Net Income (FY)846.3 M
Net Income (Quarterly QoQ Growth)-4.69
Net Income (Quarterly YoY Growth)50.16
Net Income (TTM YoY Growth)-0.82
Total Revenue (FY)4.6 B

Valuation

Enterprise Value/EBITDA (TTM)24.98
Number of Employees2,644.00
Number of Shareholders77,028.00
Shares Float43.5 M
Price to Book (FY)8.54
Price to Earnings Ratio (TTM)49.96
Price to Revenue Ratio (TTM)9.78
Price to Sales (FY)10.17
Total Shares Outstanding102.1 M
Selling & Admin expenses Ratio (FY)21.63
Selling & Admin expenses Ratio (TTM)30.61

Balance Sheet

Total Assets (Annual YoY Growth)20.09
Total Debt (Annual YoY Growth)34.94
Total Liabilities (FY)3.1 B
Cash & Equivalents (FY)241.8 M
Cash and short term investments (FY)2.6 B

Operating Metrics

Dividends

Dividend Yield Forward0.22
Dividends Paid (FY)-102,111,000.00
Dividends per Share (FY)1.00

Margins

Net Margin (FY)18.43
Net Margin (TTM)19.62
Gross Margin (FY)49.00
Gross Margin (TTM)57.97
Operating Margin (FY)26.71
Operating Margin (TTM)27.37
Pretax Margin (TTM)26.32

Related Companies (Peers) to Vijaya Diagnostic Centre Limited (VIJAYA)

Price2,339.60 -51.35 (-2.15%)52 Week High2,750.00
ISININE600L0102452 Week Low1,762.05
IndustryMedical/Nursing ServicesVolume177.9 T
SectorHealth ServicesP/E Ratio TTM73.86
Market Cap199.4 B1 Year Beta0.54
Technical Rating of
Dr. Lal Path Labs Ltd. (LALPATHLAB) is an Indian diagnostic laboratory chain. It was founded in 1983 and is headquartered in Delhi, India. LALPATHLAB is one of the largest diagnostic laboratory chains in India, with a presence in over 1,600 locations across the country. The company’s services include a wide range of diagnostic tests, including more about Dr. Lal Path Labs Ltd. (LALPATHLAB)

Price650.25 -2.35 (-0.36%)52 Week High699.70
ISININE08LI0102052 Week Low353.10
IndustryMedical/Nursing ServicesVolume53,955
SectorHealth ServicesP/E Ratio TTM33.30
Market Cap20.4 B1 Year Beta-0.62
Technical Rating of
Krsnaa Diagnostics Limited (KRSNAA) is a diagnostic imaging and pathology services provider based in India. It was founded in 2009 by Dr. Ashish Jain and is headquartered in Pune, Maharashtra. The company has a network of over 100 diagnostic centers across India. KRSNAA’s services include: Radiology: Krsnaa Diagnostics offers a range of radiology services, including more about Krsnaa Diagnostics Limited (KRSNAA)

Price83.95 -1.05 (-1.24%)52 Week High108.00
ISININE947I0101752 Week Low55.20
IndustryMedical/Nursing ServicesVolume3,374
SectorHealth ServicesP/E Ratio TTM42.72
Market Cap1.7 B1 Year Beta0.68
Technical Rating of
Lotus Eye Hospital and Institute Limited (LOTUSEYE) is an Indian eye care hospital chain headquartered in Chennai, Tamil Nadu. It was founded in 1986 by Dr. V. G. Raman. LOTUSEYE is one of the leading eye care hospital chains in India. LOTUSEYE offers a range of eye care services, including: Cataract surgery: LOTUSEYE offers cataract more about Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Price137.10 -2.55 (-1.83%)52 Week High195.00
ISININE0CG60101652 Week Low76.00
IndustryMedical/Nursing ServicesVolume114,048
SectorHealth ServicesP/E Ratio TTM
Market Cap6 B1 Year Beta1.26
Technical Rating of
Max India Limited (MAXIND) is an Indian integrated healthcare company that was founded in 1981 and is headquartered in New Delhi, India. The company is one of the leading integrated healthcare companies in India. MAXIND has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and more about Max India Limited (MAXIND)

Price1,417.75 -3.15 (-0.22%)52 Week High1,791.20
ISININE112L0102052 Week Low1,171.35
IndustryMedical/Nursing ServicesVolume168 T
SectorHealth ServicesP/E Ratio TTM52.67
Market Cap72.7 B1 Year Beta0.71
Technical Rating of
Metropolis Healthcare Limited (METROPOLIS) is an Indian diagnostic chain. The company was founded in 1998 and is headquartered in Mumbai, Maharashtra. Metropolis Healthcare Limited is one of the leading diagnostic chains in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian diagnostic market and more about Metropolis Healthcare Limited (METROPOLIS)

Price562.45 -6.35 (-1.12%)52 Week High768.25
ISININE594H0101952 Week Low415.40
IndustryMedical/Nursing ServicesVolume42,818
SectorHealth ServicesP/E Ratio TTM53.85
Market Cap30.1 B1 Year Beta0.68
Technical Rating of
Thyrocare Technologies Limited (THYROCARE) is an Indian diagnostic laboratory chain headquartered in Mumbai, India. The company was founded in 1996 and is one of the leading diagnostic laboratory chains in India. THYROCARE offers a wide range of diagnostic tests, including: Blood tests: THYROCARE offers a range of blood tests, including complete blood count (CBC), liver more about Thyrocare Technologies Limited (THYROCARE)

Vijaya Diagnostic Centre Limited (VIJAYA) Related Indices

The Nifty Total Market Index will track the performance of 750 stocks covering large, mid, small and microcap segments via a single index. All stocks that are part of Nifty 500 index and Nifty Microcap 250 index form part of the Nifty Total Market index. Stock’s weight is based on its free-float market capitalization. more about Nifty Total Market

The Nifty 500 represents the top 500 companies based on full market capitalisation and average daily turnover from the eligible universe. It represents about 94% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all Index constituents is approximately 87% of the traded value of all stocks on NSE. more about Nifty 500

The Nifty500 Multicap 50:25:25 index aims to measure the performance of portfolio of large, mid and small market capitalisation companies with target weights assigned to each size segment. The Nifty500 Multicap 50:25:25 index includes all companies that are part of Nifty 500 index. While in Nifty 500 index, the total weight of each size segment (Large, Mid and Small cap) is based on the total free float market capitalisation of all stocks falling within that size segment, in Nifty500 Multicap 50:25:25 index, the total weight of each of these three segments (Large, Mid and Small cap) is fixed at 50%, 25% and 25% respectively at every quarterly rebalance date. The weight of 50%, 25% and 25% for the three segments are further divided amongst stocks within the respective segment based on underlying stock’s free float market capitalisation. Weight of each size segment may be different from its respective capped level between two rebalance dates due to price drift of underlying stocks. more about Nifty500 Multicap 50:25:25

Nifty Smallcap 250 represents 250 companies (companies ranked 251-500) from Nifty 500. This index intends to measure the performance of small market capitalisation companies. The Nifty Free Float Midcap 100 Index represents about 14% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 9% of the traded value of all stocks on NSE. more about Nifty Smallcap 250

The Nifty MidSmallcap 400 Index is designed to reflect the behaviour and performance of the mid and small market capitalisation companies. The Nifty MidSmallcap 400 Index represents about 17% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 28% of the traded value of all stocks on NSE. more about Nifty MidSmallcap 400

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries